← FDA DRUG APPROVALS

FDA ANDA · ANDA089068

SULFACETAMIDE SODIUM

Sponsor: ALCON PHARMS LTD

APPLICATION
ANDA089068
TYPE
ANDA
ORIGINAL APPROVAL
1987-05-05
LATEST ACTION
1999-02-19
ROUTE
OPHTHALMIC
DOSAGE FORM
SOLUTION/DROPS
MARKETING STATUS
Discontinued

Products

SULFACETAMIDE SODIUMDiscontinued
SULFACETAMIDE SODIUM 30% · SOLUTION/DROPS · OPHTHALMIC

Approval history

1999-02-19Manufacturing (CMC) · Supplement 13AP
1999-02-02Manufacturing (CMC) · Supplement 11AP
1996-12-04Manufacturing (CMC) · Supplement 10AP
1996-04-16Manufacturing (CMC) · Supplement 9AP
1995-05-08Manufacturing (CMC) · Supplement 8AP
1993-05-17Manufacturing (CMC) · Supplement 5AP
1989-03-27Labeling · Supplement 3AP
1988-10-28Manufacturing (CMC) · Supplement 1AP
1988-10-28Manufacturing (CMC) · Supplement 2AP
1987-05-05OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →